BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 17696908)

  • 1. Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases.
    Jebreel A; England J; Bedford K; Murphy J; Karsai L; Atkin S
    Int J Exp Pathol; 2007 Aug; 88(4):271-7. PubMed ID: 17696908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.
    de la Torre NG; Buley I; Wass JA; Turner HE
    Endocr Relat Cancer; 2006 Sep; 13(3):931-44. PubMed ID: 16954441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
    Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density.
    Nagura S; Katoh R; Miyagi E; Shibuya M; Kawaoi A
    Hum Pathol; 2001 Jan; 32(1):10-7. PubMed ID: 11172289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
    La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
    Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vascular endothelial growth factor and presence of angiovascular cells in tissues from different thyroid disorders.
    Itoh A; Iwase K; Jimbo S; Yamamoto H; Yamamoto N; Kokubo M; Senda T; Nakai A; Nagagasaka A; Nagasaka T; Hibi Y; Seko T
    World J Surg; 2010 Feb; 34(2):242-8. PubMed ID: 20041248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions.
    Bourlev V; Volkov N; Pavlovitch S; Lets N; Larsson A; Olovsson M
    Reproduction; 2006 Sep; 132(3):501-9. PubMed ID: 16940291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemical profile of angiogenesis in the thyroid gland in various thyroid diseases].
    Rurua NZ; Gogiashvili LE; Tsagareli ZG
    Georgian Med News; 2013 Dec; (225):97-104. PubMed ID: 24423685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors.
    Lewy-Trenda I; Wierzchniewska-Ławska A
    Pol J Pathol; 2002; 53(3):129-32. PubMed ID: 12476614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
    Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
    Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.
    Al-Dissi AN; Haines DM; Singh B; Kidney BA
    Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S; Bezdekova M; Brychta T; Tichy M
    Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor--marker for proliferation in thyroid diseases?
    Malkomes P; Oppermann E; Bechstein WO; Holzer K
    Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):6-13. PubMed ID: 23329570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of vascular endothelial growth factor and its receptors, VEGFR-1 and VEGFR-2, in medullary thyroid carcinoma.
    Capp C; Wajner SM; Siqueira DR; Brasil BA; Meurer L; Maia AL
    Thyroid; 2010 Aug; 20(8):863-71. PubMed ID: 20615131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression.
    Yang J; Wu HF; Qian LX; Zhang W; Hua LX; Yu ML; Wang Z; Xu ZQ; Sui YG; Wang XR
    Asian J Androl; 2006 Mar; 8(2):169-75. PubMed ID: 16491267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic markers in canine lymphoma tissues do not predict survival times in chemotherapy treated dogs.
    Wolfesberger B; Tonar Z; Fuchs-Baumgartinger A; Walter I; Skalicky M; Witter K; Thalhammer JG; Pagitz M; Kleiter M
    Res Vet Sci; 2012 Jun; 92(3):444-50. PubMed ID: 21596405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.